FDA Grants Fast Track Designation To Nektar’s Amphotericin B Inhalation Powder (ABIP)
Nektar Therapeutics (NASDAQ:NKTR) announced today the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Amphotericin B Inhalation Powder (ABIP) for prevention of pulmonary fungal infections in patients at risk for aspergillosis due to immunosuppressive therapy, including those receiving organ or stem cell transplants, or treated with chemotherapy or radiation for hematologic […]
